Navigation Links
Oncolytics Biotech Inc. Announces Clinical Update Conference Call
Date:11/3/2008

CALGARY, Nov. 3 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY), will host a conference call and webcast on Tuesday, November 4, 2008 at 8:00 a.m. MT (10:00 a.m. ET) to update investors on recent clinical trial results for REOLYSIN(R), and to announce the selection of the Company's first pivotal trial.

To access the conference call by telephone, dial 1-416-644-3420 or 1-800-589-8577. A live audio webcast will also be available at the following link:

http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=2455860, or through the Company's website at http://www.oncolyticsbiotech.com. Please connect at least 15 minutes prior to the webcast to ensure adequate time for any software download that may be needed. A replay of the webcast will be available at http://www.oncolyticsbiotech.com and will also be available by telephone through November 11, 2008. To access the telephone replay, dial 1-416-640-1917 or 1-877-289-8525 and enter reservation number 21287371 followed by the number sign.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit http://www.oncolyticsbiotech.com

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Oncolytics Biotech Inc. Collaborators Present Positive Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting
2. Oncolytics Biotech Inc. Collaborators Present Positive Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting
3. Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting
4. Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting
5. Oncolytics Biotech Inc. Collaborators Present Reovirus and Melanoma Research at EORTC-NCI-AACR Symposium
6. Oncolytics Biotech Inc. Collaborators to Present Preclinical Combination REOLYSIN(R) and Cisplatin Research at EORTC-NCI-AACR Annual Meeting
7. Media Advisory - Oncolytics Biotech Inc. to Present at BIO Investor Forum 2008
8. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
9. Oncolytics Biotech Inc. Completes Initial Scale Up of Manufacturing Process for REOLYSIN(R) to Commercial Scale
10. Media Advisory - Oncolytics Biotech Inc. to Present at Maxim Group Growth Conference
11. Oncolytics Biotech Inc. Announces Issuance of 28th U.S. Patent

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)..., WELLINGTON, Colo., Nov. 5 The en...towns in the western U.S. This rare carnivore fee...sceptible to plague and often entire population di...fe Service (FWS) has implemented a ferret breeding...errets into their formerly native habitat. Unfort...
(Date:11/5/2009)..., SAN DIEGO, Nov. 5 Imag... today that William Spencer, President and CEO of ... at the 2nd annual LD MICRO Conference on Thursday... in Los Angeles. ,, About LD MICRO ,, LD MIC...cuses on finding undervalued companies in the micr...
(Date:11/5/2009)..., Conference Call on Thursday, November 5, 2009 at...COUVER Nov. 5 /PRNewswire-FirstCall/ - OncoGenex P...) (NASDAQ: OGXI ) today reported unaudited financ...ended September 30, 2009 and reviewed the Company,...The following consolidated results reflect the ope...
(Date:11/5/2009)..., LYNBROOK, N.Y., Nov. 5 ... a biopharmaceutical company developing first-in-c...ts financial results for the third quarter ended S... that, in September of this year, the FDA,s Arthri... a vote of 12-0, the approval of XIAFLEX(TM) for t...
Breaking Biology Technology:Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5
... federal Food and Drug Association today approved ...ensity system designed to help doctors detect, dia...ease characterized by low bone mass and increased ...he disease process. The system also enables clinic... ascertain fat distribution. , ,In addition, GE,s...
...et for women entrepreneurs? , ,The market is good... of women-owned businesses and the revenue from th...inesses combined. , ,Women-owned businesses are l...oney to back a woman-owned business, howevernow, t...ited to Wisconsin, but is national, and it spans t...
...ew Jersey - Bruker AXS Inc. announced an agreem...oanalysis business, with annual revenues of $5-6 m...c . The terms of the transaction were not disclose... fourth quarter of 2005. , ,Bruker previously anno...een reached to acquire Roentec AG , an X-ray micr...
Other Biology Technology:Women and Capital: Two words that dont always marry 2Women and Capital: Two words that dont always marry 3Women and Capital: Two words that dont always marry 4
(Date:11/4/2009)..., Heavy traffic corridors in the cities of Long B...nt proportion of preventable childhood asthma, and...ns on the disease has likely been underestimated, ...hern California (USC). , The study, which appea...f Public Health , estimated that nine percent of a...
(Date:11/4/2009)..., The Singapore laboratory that deciphered the DN...ish) and elephant shark, has joined The Genome 10K...luable repository of DNA sequences on 10,000 speci...n a scale that currently can not be achieved. , ... in a paper published in the Nov. 5, 2009 issue of...
(Date:11/4/2009)..., MADISON, N.J., Oct. 20 /PRNewswire-FirstCal..., the world,s leading provider of diagnostic testi...he third quarter ended September 30, 2009, income ...r $1.02 per diluted share, from $160 million, or $...008. In 2008, third quarter results were reduced b...
Breaking Biology News(10 mins):USC study finds big air pollution impacts on local communities 2Singapore scientists join international study of 10,000 vertebrates' genomes 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17 New Way to Make Stem Cells 3F 59148 1 New Way to Make Stem Cells 3F 59148 2Discovering the Voice of Hospice and Palliative Care Worldwide 3A World Hospice and Palliative Care Day October 10 2009 59143 1Discovering the Voice of Hospice and Palliative Care Worldwide 3A World Hospice and Palliative Care Day October 10 2009 59143 2Emerging Consensus to Create a Health Internet With Broad Consumer Engagement 59138 1Emerging Consensus to Create a Health Internet With Broad Consumer Engagement 59138 2Emerging Consensus to Create a Health Internet With Broad Consumer Engagement 59138 3Emerging Consensus to Create a Health Internet With Broad Consumer Engagement 59138 4
..., HONG KONG, April 9 /PRNewswire-Asia/ -- Futr... of fingerprint recognition software and hardware,... USB2.0 Mini Fingerprint,Scanner. , FS90 uses ...quality image,in a very small form factor. Its siz...rger than one half of Futronic FS80 USB2.0 Fingerp...
..., With more than 30 muscles in your arm, controll...hrowing a baseball -- is a complex task that poten..., But researchers at Northwestern University have... by stimulating groups of muscles rather than indi...ier to restore muscle movements in people who have...
..., Boston, MA -- Strong evidence developed at Harv...hows that sugary drinks are an important contribut...etes in the United States. Faced with these growin...nt of Nutrition at HSPH believe beverage manufactu...t take action to help Americans choose healthier d...
Other Biology News:Futronic Launches FS90 USB2.0 Mini Fingerprint Scanner 2Grouping muscles to make controlling limbs easier 2Nutrition experts propose new class of low-sugar drinks to help stem obesity and diabetes epidemics 2Nutrition experts propose new class of low-sugar drinks to help stem obesity and diabetes epidemics 3
Chicken Anti-Bacterial ytzF Polyclonal Antibody, Unconjugated from Abcam
Newborn Calf Serum - 100mL from Biomeda Corporation
Synaptic Vesicle I Sampler Kit from BD Biosciences Pharmingen
Hybridization Chamber from Aviva Systems Biology
Biology Products: